Outset Medical, Inc.
OM
$3.53
$0.051.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.20% | 37.70% | 38.50% | 32.56% | 25.94% |
| Total Depreciation and Amortization | -24.21% | -15.64% | -10.22% | -5.50% | -1.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.00% | -22.64% | -24.54% | -2.27% | -13.07% |
| Change in Net Operating Assets | 108.56% | 111.72% | 83.79% | -317.54% | -3,223.16% |
| Cash from Operations | 60.17% | 57.11% | 50.95% | 27.52% | 11.47% |
| Capital Expenditure | 12.50% | 67.85% | 63.06% | 77.18% | 73.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -192.40% | -88.18% | -55.88% | 251.62% | 21.26% |
| Cash from Investing | -193.98% | -90.22% | -55.38% | 297.57% | 25.19% |
| Total Debt Issued | 47.72% | -1.48% | -1.48% | -1.48% | 100.22% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.02% | -72.07% | -91.56% | -91.63% | -78.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.22% | -46.52% | -48.64% | -48.67% | 55.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -259.46% | 204.65% | 15.57% | 1,143.70% | 1,282.22% |